Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Revenue | ||||
| Total revenue | $ 6,092,974 | $ 1,657,687 | $ 9,626,772 | $ 4,586,341 |
| Cost of Revenues | ||||
| Total cost of revenues | 391,057 | 203,858 | 668,220 | 1,045,786 |
| Gross Profit | 5,701,917 | 1,453,829 | 8,958,552 | 3,540,555 |
| Operating Expenses | ||||
| Research and development | 2,008,870 | 406,140 | 3,105,175 | 806,556 |
| Selling, general and administrative expenses | 11,449,054 | 9,494,966 | 21,705,611 | 14,586,238 |
| Total operating expenses | 13,457,924 | 9,901,106 | 24,810,786 | 15,392,794 |
| Loss from operations | (7,756,007) | (8,447,277) | (15,852,234) | (11,852,239) |
| Other income (expenses) | ||||
| Interest income, net | 380,735 | 425,670 | 886,791 | 887,539 |
| Grant income | 71,095 | |||
| Loss on change in fair value of warrant liabilities | (1,414,267) | (5,172,091) | (290,195) | (4,024,209) |
| Loss on foreign currency contracts | (42,251) | (42,251) | ||
| Other income (expenses) | 42,050 | (5,530) | 30,131 | (6,487) |
| Total other income (expenses) | (1,033,733) | (4,751,951) | 584,476 | (3,072,062) |
| Net loss and comprehensive loss | $ (8,789,740) | $ (13,199,228) | $ (15,267,758) | $ (14,924,301) |
| Weighted average shares outstanding, basic | 21,774,104 | 16,020,702 | 21,768,115 | 16,020,015 |
| Net loss per share, basic | $ (0.4) | $ (0.82) | $ (0.7) | $ (0.93) |
| Adjusted net loss, diluted | $ (8,789,740) | $ (13,199,228) | $ (15,629,682) | $ (14,924,301) |
| Weighted average outstanding stock, diluted | 21,774,104 | 16,020,702 | 21,879,362 | 16,020,015 |
| Net loss per share, diluted | $ (0.4) | $ (0.82) | $ (0.71) | $ (0.93) |
| Product, net | ||||
| Revenue | ||||
| Total revenue | $ 6,041,506 | $ 1,576,411 | $ 9,545,327 | $ 1,923,340 |
| Licensing | ||||
| Revenue | ||||
| Total revenue | 51,468 | 81,276 | 81,445 | 2,663,001 |
| Cost of product sales, excluding amortization of intangible assets | ||||
| Cost of Revenues | ||||
| Total cost of revenues | 277,466 | 105,354 | 526,319 | 131,895 |
| Cost of licensing revenue | ||||
| Cost of Revenues | ||||
| Total cost of revenues | 39,362 | 93,118 | 62,285 | 903,118 |
| Amortization of intangible assets | ||||
| Cost of Revenues | ||||
| Total cost of revenues | $ 74,229 | $ 5,386 | $ 79,616 | $ 10,773 |
| X | ||||||||||
- Definition Amount of gain loss of warrant liabilities. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in income from government assistance, classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions. No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|